Allston, MA, United States of America

Minsheng He

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Mclean Hospital Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Minsheng He. Retrieved from https://idiyas.com/inventor/minsheng-he-8abrmtl7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Minsheng He: Innovator in Salvinorin Research

Introduction

Minsheng He is a notable inventor based in Allston, MA (US). He has made significant contributions to the field of pharmacology, particularly through his research on salvinorin derivatives. His work focuses on the therapeutic potential of these compounds in treating mood disorders.

Latest Patents

Minsheng He holds a patent for "Salvinorin derivatives and uses thereof." This invention features salvinorin compositions that are selective for kappa opioid receptors. The patent outlines methods of treating mania by using a selective kappa receptor agonist. Additionally, it describes methods for treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions. He has 1 patent to his name.

Career Highlights

He is affiliated with the McLean Hospital Corporation, where he conducts his research. His work has garnered attention for its innovative approach to addressing complex mood disorders.

Collaborations

Minsheng He collaborates with esteemed colleagues, including Cécile Béquin and William A Carlezon. Their combined expertise enhances the research and development of therapeutic applications for salvinorin derivatives.

Conclusion

Minsheng He is a pioneering inventor whose work on salvinorin derivatives holds promise for the treatment of mood disorders. His contributions to pharmacology continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…